Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Medico Intercontinental has informed that the Board of Directors of the Company at its meeting held today i.e., August 12, 2019, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on March 31, 2019 along with Limited Review report issued by V Goswami & Co, Statutory Auditors of the Company.
The above information is a part of company’s filings submitted to BSE.
